Ensign Peak Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
Ensign Peak Advisors's NEO Position: Q2 2026 in Review
Ensign Peak Advisors held its NeoGenomics (NEO) position steady in Q2 2026 at 8,990 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1540.
Ensign Peak Advisors first reported a position in NEO in Q4 2019 and has held it in 25 quarters since. The position peaked at $4.97M in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Ensign Peak Advisors held 8,990 shares of NeoGenomics worth $131K as of Q2 2026.
- Ensign Peak Advisors left its NeoGenomics share count unchanged in Q2 2026.
- NeoGenomics made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1540 holding.
- Ensign Peak Advisors first reported a position in NeoGenomics in Q4 2019 and has held it in 25 quarters since.
- Ensign Peak Advisors's NeoGenomics position peaked at $4.97M in Q3 2021.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.